Specifically, activation of JAK receptors was associated with classical GBM-subtype [80, 81], which could be in concordance with the observed association between this aggressive subtype and the downregulation of SSTR2 expression (main octreotide target). This evidence concerns the gene SSTR2 and glioblastoma.